Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: Early diagnosis is the key to successful treatment

Experimental and Clinical Transplantation

Volumn 7, Issue 3, 2009, Pages 168-172

  Tigen, Elif ^a   Tigen, Kursat ^b   Karaahmet, Tansu ^b   Odabasi, Zekaver ^a   Korten, Volkan ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Galactomannan antigen; Heart transplantation; Opportunistic infections

Indexed keywords

CEFTRIAXONE; CYCLOSPORIN; GANCICLOVIR; MEROPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; VALGANCICLOVIR; VORICONAZOLE;

ACUTE GRAFT REJECTION; ADULT; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; ASPERGILLUS; CARDIAC GRAFT REJECTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONCURRENT INFECTION; CONGESTIVE CARDIOMYOPATHY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG PULSE THERAPY; EARLY DIAGNOSIS; GRAFT RECIPIENT; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; INFECTION PREVENTION; LOADING DRUG DOSE; LUNG ASPERGILLOSIS; MALE; ORTHOTOPIC TRANSPLANTATION; PNEUMONIA; POSTOPERATIVE INFECTION; STEROID THERAPY;

ACUTE DISEASE; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; CARDIOMYOPATHY, DILATED; CYTOMEGALOVIRUS INFECTIONS; EARLY DIAGNOSIS; GANCICLOVIR; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PULSE THERAPY, DRUG; PYRIMIDINES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIAZOLES;

EID: 75149180217     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ergin F, Arslan H, Azap A, Demirhan B, Karakayali H, Haberal M. Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature. Transpl Int. 2003;16(4):280-286.
2. Hagerty JA, Ortiz J, Reich D, Manzarbeitia C. Fungal infections in solid organ transplant patients. Surg Infect (Larchmt). 2003;4(3):263-271.
3. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18(1):44-69.
4. Bonaros NE, Kocher A, Dunkler D, et al. Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients. Transplantation. 2004;77(6):890-897.
5. Li F, Kenyon KW, Kirby KA, Fishbein DP, Boeckh M, Limaye AP. Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients. Clin Infect Dis. 2007;45(4):439-447.
6. Altiparmak MR, Apaydin S, Trablus S, et al. Systemic fungal infections after renal transplantation. Scand J Infect Dis. 2002;34(4):284-288.
7. Rocamora N, Tormo AM, Franco A, Alvarez Avellán L, Olivares J. Fever and cavitary infiltrate in a renal transplant recipient [in Spanish]. Nefrologia. 2004;24(suppl 3):16-20.
8. Siu YP, Leung KT, Tong MK, Kwok YL, Wong PK, Kwan TH. Fatal case of Aspergillus coinfection in a renal transplant recipient suffering from cytomegalovirus pneumonitis. Nephrology (Carlton). 2005;10(6):619-622.
9. Dunn DL, Mayoral JL, Gillingham KJ, et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation. 1991;51(1):98-106.
10. Dunn DL, Gillingham KJ, Kramer MA, et al. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation. 1994;57(6):876-884.
11. [No authors listed] Cytomegalovirus. Am J Transplant. 2004;4(suppl 10):51-58.
12. Legendre C, Pascual M. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences. Clin Infect Dis. 2008;46(5):732-740.
13. Uknis ME, Dunn L. Cytomegalovirus infection and disease after solid organ transplantation: Epidemiology, prevention and therapy. Transplant Rev. 2000;14(4):199-209.
14. Simmons RL, Lopez C, Balfour H Jr, Kalis J, Rattazzi LC, Najarian JS. Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg. 1974;180(4):623-634.
15. Fisher RA. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation. Transpl Infect Dis. 2009;Feb 6. [Epub ahead of print]
16. Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol. 2005;16(6):1758-1774.
17. Boeckh M, Nichols WG. Immunosuppressive effects of betaherpesviruses. Herpes. 2003;10(1):12-16.
18. Sparrelid E, Emanuel D, Fehniger T, Andersson U, Andersson J. Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell-mediated cytotoxicity. Transplantation. 1997;63(12):1782-1789.
19. Montoya JG, Chaparro SV, Celis D, et al. Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis. 2003;37(suppl 3): S281-S292.
20. Muñoz P, Rodríguez C, Bouza E, et al. Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am J Transplant. 2004;4(4):636-643.
21. Schelenz S, Goldsmith DJ. Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients. J Infect. 2003;47(4):336-343.
22. Brown RS Jr, Lake JR, Katzman BA, et al. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation. 1996;61(4):666-669.
23. Lenner R, Padilla ML, Teirstein AS, Gass A, Schilero GJ. Pulmonary complications in cardiac transplant recipients. Chest. 2001;120(2):508-513.
24. Cisneros JM, Muñoz P, Torre-Cisneros J, et al. Pneumonia after heart transplantation: a multi-institutional study. Spanish Transplantation Infection Study Group. Clin Infect Dis. 1998;27(2):324-331.
25. Dummer JS, Hardy A, Poorsattar A, Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation. 1983;36(3):259-267.
26. Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS. Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg. 1983;198(5):622-629.
27. Park YS, Seo JB, Lee YK, et al. Radiological and clinical findings of pulmonary aspergillosis following solid organ transplant. Clin Radiol. 2008;63(6):673-680.
28. Paterson DL, Singh N, Gayowski T, Marino IR. Pulmonary nodules in liver transplant recipients. Medicine (Baltimore). 1998;77(1):50-58.
29. Copp DH, Godwin JD, Kirby KA, Limaye AP. Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients. Am J Transplant. 2006;6(11):2759-2764.
30. Wheat LJ. Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis. 2003;5(4):158-166.
31. Wieland T, Liebold A, Jagiello M, Retzl G, Birnbaum DE. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation. J Heart Lung Transplant. 2005;24(1):102-104.
32. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408-415.
33. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-1821.